Companion Animal Drugs Market Research Report with Revenue, Gross Margin, Market Share and Future Prospects till 2026

1. Companion Animal Drugs Market - Size, Share, Companion Animal Drugs Market - Size, Share, Growth, Outlook, and Opportunity Analysis, Growth, Outlook, and Opportunity Analysis, 2018-2026 2018-2026 Companion animals are domesticated animals which are kept primarily for person’s companionship and enjoyment rather than as a livestock, working animal or laboratory animal. Companion animal include dog, cat, fish, bird, horse, rabbit, hamster, guinea pig, and ferret. According to the National Pet Owners Survey in 2017, conducted by American Pet Products Association (APPA), around 68% of the household owns a companion animal or pet in U.S. Companion animal drug include veterinary and over-the-counter drugs, supplements, nutraceuticals, vaccines, antibiotics and parasiticides, which are used in the treatment of disease associated with digestive system, immunological system, reproductive system, respiratory, and urinary system. Request Sample Copy of Research Report: https://www.coherentmarketinsights.com/insight/request-sample/1203 According to the report published by Federal Trade Commission (FTC), in 2015, U.S. spent around US$ 58 billion in 2014 on their companion animals, which include food, veterinary care, prescription, and OTC medications, and other pet services and products. Moreover, U.S. companion animal drugs market is significantly growing in both prescription and non-prescription based medications. Growing rate of companion animal ownership, progressive rate in pet health insurance, and longer life expectancy of companion animals due to the advances in animal health medication, expected to drive the growth of companion animal drugs market in the near future. According to the North American Pet Health Insurance Association (NAPHIA), in 2015, there is an increase of US$ 774 million in overall gross written premium (GWP), accounting to 17.2 percent growth in GWP. In 2015, around 1.6 million pets got secured with health insurance, increasing to 12% from 2014 to 2015. Growing obesity in pets fuels the growth of the companion animal drugs market According to the report by Association for Pet Obesity Prevention (APOP), in 2016, there is a continuous increase in pet obesity, affecting around 54% of dogs and 59% of cats in U.S. Pet obesity is a major problem in U.S., which increases the pain and suffering and also affects the life

2. expectancy of companion animal or pet. According to APOP, factors causing pet obesity include negligence of pet owners and veterinary professionals in providing nutritional diet such as corn, grains, and raw and organic diet. In 2016, According to the stats by American Pet Products Association (APPA), around 41.9 million dogs and 50.5 million cats were classified into overweight or obese category by veterinary healthcare professionals. Report includes chapters which deeply display the following deliverable about industry : • Companion Animal Drugs Market Research Objective and Assumption • Companion Animal Drugs Market Purview - Report Description, Executive Summary, and Coherent Opportunity Map (COM) • Companion Animal Drugs Market Dynamics, Regulations, and Trends Analysis - Market Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis • Global Companion Animal Drugs Market, By Regions • Companion Animal Drugs Market Competition by Manufacturers including Production, Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type. • Companion Animal Drugs Market Manufacturers Profiles/Analysis including Company Basic Information, Manufacturing Base and Its Competitors. • Companion Animal Drugs Market Manufacturing Cost Analysis including Key Raw Materials and Key Suppliers of Raw Materials. • Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials Sourcing and Downstream Buyers • Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market Positioning and Distributors/Traders List. • Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer Preference Change and Economic/Political Environmental Change. • Companion Animal Drugs Market Forecast including Production, Consumption, Import and Export Forecast by Type, Applications and Region. • Research Findings and Conclusion Key Players in the Global Companion Animal Drug Market Some of the major players operating in the companion animal drugs market include Merck Animal Health, Elanco, Zoetis, Boehringer Ingelheim GmbH, Virbac, Ceva Sante Animale, Bayer AG, Dechra Pharmaceuticals PLC, and Vetoquinol SA. Inquire Here Before Purchase: https://www.coherentmarketinsights.com/insight/talk-to-analyst/1203

3. Companion animal drugs market taxonomy: By Product Type: Antibiotics Parasiticides • Ecto- parasiticides • Endo- parasiticides Anti-inflammatory drugs Nutritional drugs Behavioral drugs Heartworm drugs Skincare drugs Vaccines • • • • • • • • By Animal Type: Feline Canine Equine Others • • • • By Distribution Channel: Veterinary hospitals Veterinary clinics Pharmacy/ drug store • • • About Coherent Market Insights Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154

4. Tel: +1-206-701-6702 Email: sales@coherentmarketinsights.com